The value of ergometrine in the treatment of postpartum hemorrhage caused by uterine atony
麦角新碱在宫缩乏力性产后出血治疗中的价值

摘要

目的 分析宫缩乏力性从产后出血患者使用麦角新碱的效果。方法 从2020年1月-2022年1月期间因宫缩乏力性产后出血入院的患者内随机选择70例，依据治疗形式分组，即实验与对照，各组35例。对照组病患均使用缩宫素，实验组病患则联合麦角新碱，对比效果。结果 实验组中产妇术中出血、术后出血控制以及产后整体恢复效果比对照组产妇更佳，凝血功能指标高于对照组，两组比较有差异性，P＜0.05。实验组疗效优于对照组，P＜0.05。结论 对宫缩乏力性产后出血患者实施麦角新碱治疗，可提升疗效，改善症状，减少出血量。

Abstract

Objective: To analyze the effect of ergometrine on postpartum hemorrhage due to uterine atony.
Methods: from January 2020 to January 2022, 70 patients with postpartum hemorrhage due to uterine atony were randomly selected and grouped according to the treatment form, namely, experiment and control, with 35 patients in each group. The patients in the control group were treated with oxytocin, and the patients in the experimental group were treated with ergometrine to compare the effects.
Results: the control of intraoperative bleeding, postoperative bleeding and the overall recovery of postpartum in the experimental group were better than those in the control group, and the coagulation function index was higher than that in the control group. There was a difference between the two groups (P < 0.05). The curative effect of the experimental group was better than that of the control group (P < 0.05).
Conclusion  : ergometrine treatment for postpartum hemorrhage caused by uterine atony can improve the curative effect, improve symptoms and reduce bleeding volume.